Foltira Tablet
NDC Package 85477-921-30
Package Information
Foltira (folate, vitamin d3) tablets is foltira is for patients with unique nutritional needs requiring increased folate levels and Vitamin D supplementation due to Vitamin D deficiency. This formulation utilizes a tablet delivery system. Marketed by Oncora Pharma, Llc, this product is identified by NDC 85477-921.
Identification & Billing
- RxCUI: 1720258 - vitamin D3 125 MCG (5000 UNT) / folate 1700 MCG DFE (1000 mcg folic acid) Oral Tablet
- RxCUI: 1720258 - cholecalciferol 5000 UNT / folic acid 1 MG Oral Tablet
- RxCUI: 1720258 - Cholecalciferol 5000 UNT / folate 1 MG Oral Tablet
- RxCUI: 1720258 - vitamin D3 125 MCG / folic acid 1000 MCG Oral Tablet
- RxCUI: 1720258 - vitamin D3 5000 UNT / folic acid 1 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 85477 - Oncora Pharma, Llc
- 85477-921 - Foltira
- 85477-921-30 - 30 TABLET in 1 BOTTLE
- 85477-921 - Foltira
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 85477-921-30 identifies a specific commercial package of 30 tablet in 1 bottle of Foltira, a human prescription drug labeled by Oncora Pharma, Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 30 billable units per package. This tablet is formulated for oral use and contains folate sodium; vitamin d as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Oncora Pharma, Llc on December 12, 2025. The current certification is valid through December 31, 2026.
How is this Oncora Pharma, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 85477092130. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.